Vivos (RDGL) EPS (Diluted) Growth (3y) (2014 - 2025)
Vivos (RDGL) EPS (Diluted) Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.55 Bn | 176.26 Bn | 6.27 Bn | -6.43% |
| 2 | Stryker | 128.64 Bn | 125.76 Bn | 3.81 Bn | 7.66% |
| 3 | Medtronic | 108.92 Bn | 99.70 Bn | 6.41 Bn | 3.09% |
| 4 | Boston Scientific | 68.50 Bn | 67.05 Bn | 3.61 Bn | 62.91% |
| 5 | Edwards Lifesciences | 47.84 Bn | 44.17 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.25 Bn | 25.96 Bn | 1.98 Bn | 29.56% |
| 7 | Dexcom | 28.23 Bn | 27.11 Bn | 750.30 Mn | 63.42% |
| 8 | Smith & Nephew | 26.93 Bn | 26.35 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.30 Bn | 2.07 Bn | 30.57% |
| 10 | Vivos | 26.71 Mn | 25.15 Mn | -3,105.00 | -5.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.86% |
| Sep 30, 2025 | -11.50% |
| Jun 30, 2025 | 14.66% |
| Mar 31, 2025 | -232.93% |
| Dec 31, 2024 | -479.26% |
| Sep 30, 2024 | -414.16% |
| Jun 30, 2024 | -110.34% |
| Mar 31, 2024 | -310.22% |
| Dec 31, 2023 | -411.70% |
| Sep 30, 2023 | -469.11% |
| Jun 30, 2023 | -497.89% |
| Mar 31, 2023 | -197.66% |
| Dec 31, 2022 | -280.88% |
| Sep 30, 2022 | -155.57% |
| Jun 30, 2022 | -441.26% |
| Mar 31, 2022 | -43.60% |
| Dec 31, 2021 | -26.14% |
| Sep 30, 2021 | 80.45% |
| Jun 30, 2021 | 32.36% |
| Mar 31, 2021 | 31.62% |